Ac4ManNAz
Based on 17 publication(s) in Google Scholar
Ac4ManNAz can be taken up by cells and is an azide-containing metabolic glycoprotein labeling reagent that selectively modifies proteins. Commonly used for cell labeling, tracking and proteomic analysis. Ac4ManNAz contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Ac4ManNAz can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.94%
- CAS No.: 1213701-11-1
- 화학식: C16H22N4O10
- 분자량:430.37
-
보관:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Ac4ManNAz
More- Adv Mater. 2025 Jul 7:e2504733. [Abstract]
- Adv Mater. 2025 Jun 22:e2420113. [Abstract]
- J Extracell Vesicles. 2026 Apr;15(4):e70282. [Abstract]
- Adv Funct Mater. 2025 Nov 12.
- ACS Nano. 2025 May 27;19(20):18986-18995. [Abstract]
- Acta Pharm Sin B. 2025 Dec 23.
- Adv Sci (Weinh). 2026 May 6:e75519. [Abstract]
- Adv Sci (Weinh). 2025 Feb 8:e2416841. [Abstract]
- Acta Biomater. 2026 Jul:218:510-524. [Abstract]
- Acta Pharmacol Sin. 2025 Aug 8. [Abstract]
- Acta Biomater. 2025 Apr 10:S1742-7061(25)00265-X. [Abstract]
- Int J Nanomedicine. 2025 Nov 26:20:14185-14200. [Abstract]
- Anal Chem. 2026 Mar 24;98(11):8143-8154. [Abstract]
- Talanta. 2026 Jul 1:304:129561. [Abstract]
- Oncogenesis. 2025 Oct 1;14(1):29. [Abstract]
- Biophys J. 2026 Mar 13:S0006-3495(26)00198-0. [Abstract]
- bioRxiv. 2025 Aug 08.
-
Others
-
RT-PCR
-
Cell Imaging/Staining
-
Cell Imaging/Staining
-
RT-PCR
Biological Activity
Ac4ManNAz (0-50 μM, 72 h) upregulates MAPK activity-related genes (TLR4, THBS1, FPR1) and downregulates cell cycle, proliferation and cell adhesion-related genes like CYBB, GABRA1, SLC6A2, AKAP7)[2].
Ac4ManNAz (0-50 μM, 30 h) inhibits voltage-gated potassium channel, inhibits the cell migration and invasion in A549, and impairs the mitochondrial functions[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549
-
Concentration:50 μM
-
Incubation Time:30 h
-
Result:Inhibited cell migration.
Chemical Information
-
CAS No. 1213701-11-1
-
Appearance Solid
-
분자량 430.37
-
화학식 C16H22N4O10
-
Color White to off-white
-
SMILES
CC(O[C@@H]1[C@@H]([C@H](O[C@@H]([C@H]1OC(C)=O)COC(C)=O)OC(C)=O)NC(CN=[N+]=[N-])=O)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (17)
-
Journal Impact Factor
-
Most Recent
-
Adv Mater
A Dendritic Cell-Nanogel Conjugate for Tumor-Draining Lymph Node-Specific PD-L1 Blockade. [Abstract]2025 Jul 7:e2504733. PMID: 40619999
Ac4ManNAz purchased from MedChemExpress. Usage Cited in: Adv Mater. 2025 Jul 7:e2504733. [Abstract]
Scheme illustration of the preparation of tumor-lysate pulsed DC vaccines (DCVs). BMDCs were incubated with 50 μM Ac4ManNAz and tumor lysates for 48 h.
-
Adv Mater
Dendritic Cell-Based Biohybrid Immunomodulator Alleviates Intestinal Inflammatory Disease. [Abstract]2025 Jun 22:e2420113. PMID: 40545797 -
J Extracell Vesicles
PREDICTOR: A Non-Enzymatic Catalytic Cascade Tool for in Situ Visualization of Small Extracellular Vesicle Surface glycoRNAs. [Abstract]2026 Apr;15(4):e70282. PMID: 41979055 -
-
ACS Nano
Decoration of Biomimetic DNA Receptors on Macrophages for Precise and Logical Manipulation of Pathogen Predation. [Abstract]2025 May 27;19(20):18986-18995. PMID: 40358040 -
-
Adv Sci (Weinh)
Light-Switched Mesenchymal Stem Cells for In Situ Exosome Amplification in Craniofacial Bone Defect Reconstruction. [Abstract]2026 May 6:e75519. PMID: 42089450 -
Adv Sci (Weinh)
A Spatially Distributed Microneedle System for Bioorthogonal T Cell-Guided Cancer Therapy. [Abstract]2025 Feb 8:e2416841. PMID: 39921874 -
Acta Biomater
Strain-promoted click chemistry boosts microbubbles for targeted ultrasound imaging and cancer chemotherapy. [Abstract]2026 Jul:218:510-524. PMID: 42248283 -
Acta Pharmacol Sin
Dendritic cell-liposome conjugates reverse immunosuppressive tumor microenvironment for inhibiting colitis-associated colorectal cancer. [Abstract]2025 Aug 8. PMID: 40781495 -
Acta Biomater
Engineered bioorthogonal cell delivery system for in situ antimicrobial peptide recruitment during systemic bacterial infection. [Abstract]2025 Apr 10:S1742-7061(25)00265-X. PMID: 40220946 -
Int J Nanomedicine
Interleukin-2 Surface Displayed M1 Macrophage-Derived Extracellular Vesicles for Modulating the Tumor Microenvironment. [Abstract]2025 Nov 26:20:14185-14200. PMID: 41332502
Ac4ManNAz purchased from MedChemExpress. Usage Cited in: Int J Nanomedicine. 2025 Nov 26:20:14185-14200. [Abstract]
Ac4ManNAz (50 μM; 72 h). qRT-PCR analysis comparing the relative expression level of IL-1β between M1 macrophages and Ac4ManNAz-treated M1 macrophages (Ac4/M1).
Ac4ManNAz purchased from MedChemExpress. Usage Cited in: Int J Nanomedicine. 2025 Nov 26:20:14185-14200. [Abstract]
Ac4ManNAz (50 μM; 72 h). Fluorescence microscopy imaging of macrophages labeled with DBCO-Cy5 after Ac4ManNAz treatment. Hoechst staining shows nuclei (blue), while DBCO-Cy5 indicates successful surface labeling (red). The merged image highlights specific azide-dependent bioorthogonal chemistry, with scale bars representing 100 µm.
Ac4ManNAz purchased from MedChemExpress. Usage Cited in: Int J Nanomedicine. 2025 Nov 26:20:14185-14200. [Abstract]
Ac4ManNAz (50 μM; 72 h). Morphological comparison of M0, M1, and Ac4ManNAz-treated M1 macrophages.
Ac4ManNAz purchased from MedChemExpress. Usage Cited in: Int J Nanomedicine. 2025 Nov 26:20:14185-14200. [Abstract]
Ac4ManNAz (50 μM; 72 h). qRT-PCR results showing that with Ac4ManNAz-treated M1EV (Ac4M1EV) significantly upregulated M1 macrophage markers IL-1β and CXCL10, while downregulating the M2 macrophage marker CD206 compared with M0 macrophages.
-
Anal Chem
2026 Mar 24;98(11):8143-8154. PMID: 41810699 -
Talanta
Dual-gold nanoprobe system enables highly sensitive SERS detection of glycosylated CEs1 in HepG-2 cell culture supernatant. [Abstract]2026 Jul 1:304:129561. PMID: 41722413 -
Oncogenesis
2025 Oct 1;14(1):29. PMID: 41028727 -
Biophys J
Inhibition of endocytosis by glycans arises from steric rather than electrostatic repulsion. [Abstract]2026 Mar 13:S0006-3495(26)00198-0. PMID: 41832605 -
용액&용해도
DMSO : 100 mg/mL (232.36 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
순도&문서
-
Data Sheet (277 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.3236 mL | 11.6179 mL | 23.2358 mL | 58.0896 mL |
| 5 mM | 0.4647 mL | 2.3236 mL | 4.6472 mL | 11.6179 mL | |
| 10 mM | 0.2324 mL | 1.1618 mL | 2.3236 mL | 5.8090 mL | |
| 15 mM | 0.1549 mL | 0.7745 mL | 1.5491 mL | 3.8726 mL | |
| 20 mM | 0.1162 mL | 0.5809 mL | 1.1618 mL | 2.9045 mL | |
| 25 mM | 0.0929 mL | 0.4647 mL | 0.9294 mL | 2.3236 mL | |
| 30 mM | 0.0775 mL | 0.3873 mL | 0.7745 mL | 1.9363 mL | |
| 40 mM | 0.0581 mL | 0.2904 mL | 0.5809 mL | 1.4522 mL | |
| 50 mM | 0.0465 mL | 0.2324 mL | 0.4647 mL | 1.1618 mL | |
| 60 mM | 0.0387 mL | 0.1936 mL | 0.3873 mL | 0.9682 mL | |
| 80 mM | 0.0290 mL | 0.1452 mL | 0.2904 mL | 0.7261 mL | |
| 100 mM | 0.0232 mL | 0.1162 mL | 0.2324 mL | 0.5809 mL |